Immune Repertoire Sequencing
Home > Antibody Services > Immune Repertoire Sequencing
The General Introduction of Immune Repertoire Sequencing

Immune Repertoire refers to the set of all functionally diversified B cells and T cells in a person's circulatory system. Immune repertoire sequencing (Immuno-Seq) targets T/B lymphocytes and utilizes the 5’ Rapid Amplification of cDNA Ends (RACE) Technology. The 5’ RACE technology amplifies complementarity-determining regions (CDRs) of B cell receptors (BCRs) or T cell receptors (TCRs). The CDRs are targeted because they control the diversity of the corresponding BCRs and TCRs. Combined with high-throughput sequencing technology, the Immuno-Seq provides a comprehensive evaluation of the immune system diversity.


Synbio Technologies provides a complete antibody repertoire sequencing services, including immune repertoire sequencing and antibody CDR region sequencing. Our Immuno-Seq System is designed to assist researchers in the observation and analysis of both T and B cells; the specificity of our technology enables it to be applied to disease surveillance, antibody production, vaccine research, health examination and other related areas.
Highlights
  • Robust RACE Technology and Specially Optimized PCR Amplification Systems
  • Diversified NGS Analysis Platform
  • Optimal Success Rates and Fast Turnaround Time
  • Complete and Advanced Bioinformatic Analysis
Service Details

* For Immuno-Seq service: customers will need to submit one of the following: 1-2ml peripheral blood, splenocyte, selected immune cells, or extracted high quality RNA.

Service Deliverables Turnaround Time Price
Immune Repertoire Sequencing · NGS sequencing data · Bioinformatics analysis report 6-8 Weeks Quote
Workflow

FAQs
Resources
Get in Touch with Us
Related Services
  • Address:
    9 Deer Park Dr., Suite J-25
    Monmouth Junction, NJ 08852

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.

Accept